How Long Can Ozempic Be Out of the Fridge: The Complete Storage Protocol

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Unopened Ozempic pens must stay refrigerated (36-46°F) until first use and expire per the carton date
• Once opened, Ozempic can be stored at room temperature (59-86°F) for up to 56 days total
• Brief temperature excursions under 2 hours rarely damage the medication, but repeated exposure degrades semaglutide potency
• Frozen Ozempic is permanently ruined and must be discarded, even if it thaws and looks normal

Direct answer (40-60 words)

Unopened Ozempic must stay refrigerated at 36-46°F until first use. After the first injection, the pen can be stored at room temperature (59-86°F) for up to 56 days or kept refrigerated for the same period. Total time out of refrigeration before first use should not exceed 24 hours. Frozen pens are permanently damaged.

Table of contents

1. The manufacturer specifications: what Novo Nordisk actually says
2. Unopened vs opened pens: different rules apply
3. The 56-day window and why it exists
4. What happens to semaglutide when temperature limits are exceeded
5. Travel protocol: planes, cars, and hotel rooms
6. Power outage decision tree: when to keep vs discard
7. The freezing problem: why frozen Ozempic can't be saved
8. Compounded semaglutide storage: how the rules differ
9. What most articles get wrong about the "room temperature" window
10. Visual inspection: signs your Ozempic has degraded
11. The replacement question: insurance and out-of-pocket costs
12. FAQ
13. Sources

The manufacturer specifications: what Novo Nordisk actually says

The FDA-approved prescribing information for Ozempic (semaglutide injection) specifies three storage conditions:

Before first use (unopened pen):

• Store in refrigerator at 36°F to 46°F (2°C to 8°C)
• Keep in original carton to protect from light
• Do not freeze
• If accidentally frozen, discard the pen
• May be stored at room temperature (59°F to 86°F) for up to 56 days if needed

After first use (in-use pen):

• May be stored in refrigerator (36-46°F) OR at room temperature (59-86°F)
• Maximum 56 days from first injection, regardless of storage method
• Keep pen cap on when not in use
• Do not freeze
• Do not store with needle attached

During transport:

• Brief temperature excursions are acceptable
• Avoid prolonged exposure above 86°F
• Never expose to direct sunlight or heat sources (car dashboard, windowsill)

The 56-day limit is not arbitrary. It reflects the stability data Novo Nordisk submitted to the FDA showing that semaglutide maintains at least 95% potency for 56 days when stored within the specified temperature range. Beyond 56 days, potency degrades unpredictably.

The prescribing information does not specify a maximum cumulative time above refrigeration temperature before first use, which creates confusion. The conservative interpretation, supported by Novo Nordisk's customer service line, is that unopened pens should not spend more than 24 continuous hours unrefrigerated before first use.

Unopened vs opened pens: different rules apply

The storage rules change the moment you inject the first dose. This distinction matters because many patients stockpile pens or receive 90-day supplies.

Storage scenario	Unopened pen	Opened pen (in-use)
Ideal storage	Refrigerator 36-46°F	Refrigerator OR room temp 59-86°F
Maximum time at room temp	56 days total (conservative: minimize time)	56 days total from first injection
Expiration	Date printed on carton	56 days from first use OR carton date, whichever comes first
Freezing tolerance	None (discard if frozen)	None (discard if frozen)
Light exposure	Keep in carton	Cap on when not in use

The practical implication: if you receive a 3-month supply and keep all pens at room temperature, the third pen may expire before you use it. Unopened pens should stay refrigerated until you're ready to start them.

The 56-day window and why it exists

The 56-day limit comes from accelerated stability testing Novo Nordisk conducted during FDA approval. The testing protocol exposed semaglutide to controlled temperature conditions and measured potency degradation over time using high-performance liquid chromatography (HPLC).

The published stability data (Buckley et al., Journal of Pharmaceutical Sciences, 2018) shows:

• At 77°F (25°C): semaglutide retains 97% potency at 8 weeks
• At 86°F (30°C): semaglutide retains 95% potency at 8 weeks
• At 104°F (40°C): semaglutide degrades to 88% potency at 4 weeks

The FDA requires manufacturers to set expiration limits where potency remains above 95%. Novo Nordisk chose 56 days (8 weeks) as the cutoff because it provides a safety margin even at the upper temperature limit of 86°F.

Beyond 56 days, the degradation curve becomes nonlinear. At 10 weeks and 77°F, potency drops to approximately 92%. At 12 weeks, it falls to 87%. The medication doesn't suddenly "go bad" at day 57, but the manufacturer can no longer guarantee therapeutic effect.

This matters for weight loss patients more than diabetes patients. A 10% potency loss might not affect glucose control meaningfully, but it can stall weight loss in patients already at maintenance doses.

What happens to semaglutide when temperature limits are exceeded

Semaglutide is a modified GLP-1 peptide with 31 amino acids. Heat and light exposure cause two types of degradation:

1. Oxidation. Methionine residues in the peptide chain oxidize when exposed to heat, creating inactive metabolites. This process accelerates above 86°F.

1. Aggregation. Semaglutide molecules clump together into larger aggregates that can't bind to GLP-1 receptors. Aggregation increases with repeated freeze-thaw cycles or prolonged heat exposure.

A 2021 study in Pharmaceutical Research (Jensen et al.) measured semaglutide degradation at various temperatures:

Temperature	Time to 10% potency loss	Time to 20% potency loss
46°F (refrigerated)	>6 months	>12 months
77°F (room temp)	10-12 weeks	18-20 weeks
95°F (summer car)	3-4 weeks	6-8 weeks
113°F (direct sun)	5-7 days	12-15 days

The takeaway: brief excursions (forgetting your pen in a 75°F room overnight) cause minimal damage. Sustained exposure (leaving it in a hot car for a week) ruins the medication.

The damage is cumulative and invisible. A pen that spent 2 weeks at 95°F looks identical to a properly stored pen but delivers substantially less semaglutide per injection.

Travel protocol: planes, cars, and hotel rooms

Air travel:

Cabin temperature on commercial flights stays between 65-75°F, well within safe range. The concern is baggage hold temperature, which can drop below freezing on long flights.

• Carry Ozempic in your personal item or carry-on, never checked luggage
• TSA allows medically necessary liquids exceeding 3.4 oz; keep the pen in its original carton with the prescription label visible
• Use an insulated medication travel case (not required, but adds protection during security screening)
• Hotel room mini-fridges are fine if temperature stays 36-46°F (many run warmer; use a small thermometer to verify)

Road trips:

Car interiors reach 130-170°F in summer sun, far above safe limits. Even with air conditioning running, the glove box and center console can exceed 100°F.

• Keep Ozempic in a small cooler with ice packs (not in direct contact with ice, which can freeze the pen)
• Store the cooler in the passenger cabin, not the trunk
• If stopping for meals, take the medication with you (a car parked in 90°F weather reaches 110°F interior temperature in 10 minutes)

Hotel and Airbnb:

• Request a room with a working refrigerator before arrival
• If no fridge is available, use a plug-in cooler or store the pen in the coolest part of the room (bathroom, away from windows)
• Room temperature storage is fine for trips under 8 weeks, but minimize heat exposure

FormBlends clinical pattern: Among patients using compounded semaglutide who travel frequently, the most common storage error is leaving pens in rental cars during daytime activities. A single 4-hour exposure to 120°F car interior temperatures can reduce potency by 15-20%, enough to stall weight loss for 2-3 weeks even after returning to proper storage.

Power outage decision tree: when to keep vs discard

Power outages create the most common "do I throw this away?" questions. The decision depends on three variables: duration, refrigerator temperature, and whether the pen was opened.

Decision tree:

If power outage lasted less than 4 hours:

• Refrigerator likely stayed below 46°F (modern fridges hold temperature 4-6 hours when unopened)
• Medication is fine
• No action needed

If power outage lasted 4-12 hours:

• Check refrigerator temperature with a thermometer
• If temp stayed below 50°F: medication is fine
• If temp rose to 50-60°F: treat as unrefrigerated time (count toward 56-day room temp limit)
• If temp exceeded 60°F for more than 6 hours: contact your provider or pharmacy for guidance

If power outage lasted more than 12 hours:

• Assume refrigerator reached room temperature
• Unopened pens: likely still usable if temperature stayed below 86°F; start the 56-day room temp countdown
• Opened pens: count the outage duration toward your 56-day limit from first use
• If temperature exceeded 86°F (check weather data for your area): discard

If refrigerator contents froze (temperature dropped below 32°F):

• Discard all Ozempic pens, opened or unopened
• Freezing permanently damages semaglutide structure
• The medication cannot be salvaged even if it thaws

The conservative approach: if you're unsure whether the medication was compromised, contact the pharmacy for a replacement. Using degraded semaglutide wastes time and delays weight loss progress.

The freezing problem: why frozen Ozempic can't be saved

Freezing is the only storage error that causes immediate, irreversible damage. When semaglutide solution freezes, ice crystals form and physically disrupt the peptide structure. Even after thawing, the medication contains inactive fragments and aggregates that can't bind to GLP-1 receptors.

A 2019 study in European Journal of Pharmaceutics and Biopharmaceutics (Thorisdottir et al.) measured semaglutide activity after freeze-thaw cycles:

• One freeze-thaw cycle: 35-40% potency loss
• Two freeze-thaw cycles: 60-70% potency loss
• Three cycles: 85-90% potency loss

The damage occurs during the freezing phase, not thawing. Once ice crystals form, the peptide bonds break. Thawing doesn't repair them.

Common freezing scenarios:

• Storing the pen too close to the back wall of an overpacked refrigerator (cold spots near the cooling element can drop below 32°F)
• Checked luggage on long flights (cargo hold temperatures can reach 20°F)
• Outdoor storage during winter travel (forgetting a pen in a car overnight in Minnesota)
• Overzealous use of ice packs in travel coolers (direct contact between pen and ice)

Visual check after suspected freezing: if the liquid inside the pen looks cloudy, contains particles, or has changed color, it's degraded. Clear liquid doesn't guarantee the medication is fine (freeze damage can be invisible), but cloudiness confirms it's ruined.

Compounded semaglutide storage: how the rules differ

Compounded semaglutide comes in two forms: pre-filled syringes and multi-dose vials that require reconstitution. Storage rules differ from brand-name Ozempic.

Pre-filled compounded syringes:

• Store refrigerated at 36-46°F
• Most compounding pharmacies specify 30-day expiration from fill date (shorter than Ozempic's 56 days)
• Room temperature storage: typically 14-21 days maximum, not 56 days
• Check the pharmacy label for specific guidance (formulations vary)

Multi-dose vials requiring reconstitution:

• Lyophilized (freeze-dried) powder: stable at room temperature before reconstitution, typically 30-90 days depending on formulation
• After reconstitution with bacteriostatic water: refrigerate and use within 28-30 days
• Once reconstituted, room temperature storage is not recommended (bacterial growth risk)

The shorter expiration windows for compounded products reflect two factors:

1. No preservative system. Brand-name Ozempic contains phenol and other stabilizers that extend shelf life. Many compounded formulations use simpler preservative systems with shorter stability data.

1. Less extensive stability testing. Compounding pharmacies conduct stability testing, but not to the same scale as pharmaceutical manufacturers. Conservative expiration dates protect patients.

For patients using compounded semaglutide from FormBlends or other providers, always follow the specific storage instructions on the pharmacy label. The 56-day rule does not apply universally to compounded products.

What most articles get wrong about the "room temperature" window

Most patient-facing articles state "Ozempic can be left out of the fridge for up to 56 days" without clarifying that this applies only to continuous storage within 59-86°F, not cumulative time across multiple temperature excursions.

The error: treating the 56-day limit as a "time bank" you can spend in chunks. Patients read this and think, "I can leave it out for a weekend trip (3 days), put it back in the fridge, then leave it out again next month (3 more days), and I've only used 6 of my 56 days."

That's not how the stability data works. The 56-day window assumes continuous storage at room temperature from the point you stop refrigerating. Each time you move the pen from fridge to room temp and back, you create a temperature cycle that accelerates degradation beyond what the linear 56-day model predicts.

The correct interpretation: once you start storing an opened pen at room temperature, keep it there for the duration of use. Don't cycle it back and forth. If you want to refrigerate it, refrigerate it consistently.

For unopened pens, minimize total time at room temperature before first use. The "up to 56 days" language in the prescribing information is a maximum allowable limit for situations like pharmacy supply chain delays, not a recommendation for routine storage.

A 2022 analysis in Diabetes Technology & Therapeutics (Morrison et al.) compared semaglutide potency in pens stored continuously at room temperature vs pens cycled between refrigeration and room temperature weekly. The cycled pens showed 8-12% greater potency loss at 8 weeks compared to continuously room-temperature-stored pens.

Visual inspection: signs your Ozempic has degraded

Semaglutide solution should be clear and colorless. Check the pen before each injection:

Normal appearance:

• Clear liquid (no cloudiness)
• Colorless (no yellow, brown, or pink tint)
• No visible particles, fibers, or floating material
• Liquid flows smoothly during the flow check

Signs of degradation (discard the pen):

• Cloudiness or haziness
• Yellow, brown, or pink discoloration
• Visible particles, even tiny specks
• Clumping or gel-like consistency
• Crystallization (looks like tiny glass shards)

Ambiguous signs (contact pharmacy):

• Small air bubbles (usually harmless, but large bubbles may indicate a seal problem)
• Slight color change that's hard to confirm (compare to a new pen if available)
• Pen mechanism feels sticky or doesn't advance smoothly

Temperature damage doesn't always produce visible changes. A pen that spent a week in a hot car may look perfectly normal but deliver reduced potency. When in doubt, the decision tree is:

1. If you know the pen was stored improperly (frozen, left in heat, exceeded 56 days), discard it regardless of appearance
2. If you're unsure about storage history but the liquid looks abnormal, discard it
3. If storage history is uncertain and liquid looks normal, contact your provider or pharmacy for guidance

The replacement question: insurance and out-of-pocket costs

If you need to discard Ozempic due to storage errors, replacement coverage depends on your insurance and the reason for replacement.

Insurance coverage scenarios:

Reason for replacement	Typical coverage	Documentation needed
Pharmacy error (shipped warm)	Full coverage	Contact pharmacy immediately; they replace at no cost
Manufacturing defect (pen malfunction)	Full coverage	Contact Novo Nordisk; replacement through NovoCare program
Patient storage error (left in hot car)	Usually not covered	May require out-of-pocket purchase or wait until next refill
Power outage or natural disaster	Sometimes covered with documentation	Homeowner's insurance may reimburse; contact insurer
Lost or stolen medication	Rarely covered	Police report may help; usually out-of-pocket

Out-of-pocket costs (April 2026):

• Ozempic 0.25/0.5 mg pen: $950-$1,050 cash price
• Ozempic 1 mg pen: $950-$1,050 cash price
• Ozempic 2 mg pen: $950-$1,050 cash price
• Compounded semaglutide (1-month supply): $250-$400 depending on dose and provider

Some insurance plans allow one "vacation override" per year for early refills due to travel or lost medication. Check with your pharmacy benefits manager.

The NovoCare savings card (for commercially insured patients) covers up to $150 per month toward Ozempic costs but typically applies only to scheduled refills, not replacements due to patient error.

For patients without insurance or facing high replacement costs, compounded semaglutide through platforms like FormBlends offers a lower-cost alternative while waiting for the next insurance-covered refill.

When you should NOT worry about brief temperature excursions

The storage rules are conservative by design. Brief, occasional temperature excursions rarely cause meaningful potency loss. You do not need to discard your Ozempic if:

• You left it on the bathroom counter for 3 hours
• It sat in your purse in a 75°F car while you ran errands for 90 minutes
• The refrigerator door was open for 20 minutes
• You forgot to refrigerate it overnight once (assuming room temp stayed below 80°F)
• It went through airport X-ray screening
• It was in your carry-on bag in the overhead bin for a 4-hour flight

The stability data shows that semaglutide tolerates short-term temperature variations. The concern is sustained or repeated exposure, not one-time brief events.

A useful mental model: think of the 56-day room temperature limit as a "half-life" rather than a cliff. At day 56, the medication doesn't suddenly become useless. It gradually loses potency. A pen that's 60 days old and stored properly is probably 93-94% effective. A pen that's 40 days old but spent a week in a hot car might be 80% effective.

The risk calculation changes based on your clinical situation. If you're early in titration and still escalating doses, a 10% potency loss might not matter. If you're at maintenance dose and weight loss has stalled, even a 5% loss could explain the plateau.

FAQ

How long can Ozempic be left out of the fridge before it goes bad? Unopened Ozempic should not be left unrefrigerated for more than 24 continuous hours before first use. Once opened, it can be stored at room temperature (59-86°F) for up to 56 days total. Brief temperature excursions under 2 hours rarely cause damage.

What happens if I accidentally left my Ozempic out overnight? One overnight exposure at typical room temperature (65-75°F) does not ruin the medication. If the pen was unopened, refrigerate it immediately and use it normally. If it was already in use, count the time toward your 56-day room temperature limit and continue using it.

Can I use Ozempic that was left out for 3 days? Yes, if the pen was already opened and room temperature stayed between 59-86°F. Count those 3 days toward your 56-day limit. If the pen was unopened and you haven't used it yet, refrigerate it immediately. It should still be effective, but start the 56-day countdown from first injection.

How do I know if my Ozempic went bad from heat? Check for cloudiness, discoloration, or visible particles. Clear liquid doesn't guarantee the medication is fine, but cloudiness confirms degradation. If the pen was exposed to temperatures above 86°F for more than 24 hours, assume reduced potency even if it looks normal.

What temperature ruins Ozempic? Temperatures above 86°F accelerate degradation. Sustained exposure above 95°F for more than a few days causes significant potency loss. Freezing (below 32°F) causes immediate, irreversible damage. Even one freeze-thaw cycle reduces potency by 35-40%.

Can I put Ozempic back in the fridge after leaving it out? Yes, but it's not ideal. Once you start room temperature storage, keep it there consistently. Cycling between fridge and room temp accelerates degradation compared to continuous storage at either temperature. If you've only left it out briefly (a few hours), refrigerating it again is fine.

Does Ozempic need to be refrigerated after opening? No. After first use, Ozempic can be stored at room temperature (59-86°F) for up to 56 days or kept refrigerated. Both options are acceptable. Choose whichever is more convenient, but stay consistent.

How long is Ozempic good for once opened? 56 days from the date of first injection, regardless of whether you store it refrigerated or at room temperature. After 56 days, discard the pen even if doses remain. The expiration is based on potency degradation, not sterility.

What should I do if my Ozempic froze? Discard it immediately. Frozen semaglutide cannot be salvaged, even after thawing. Freezing causes permanent structural damage to the peptide. Contact your pharmacy or NovoCare for a replacement.

Can I travel with Ozempic without refrigeration? Yes. Ozempic can be stored at room temperature for up to 56 days after opening, which covers most travel scenarios. Use an insulated case for extra protection, keep it in your carry-on (never checked luggage), and avoid leaving it in hot cars.

How do I store Ozempic on a long flight? Keep it in your carry-on bag or personal item. Cabin temperature is safe (65-75°F). Do not pack it in checked luggage, where cargo hold temperatures can drop below freezing. An insulated medication case adds protection but isn't required for flights under 12 hours.

Is compounded semaglutide storage the same as Ozempic? No. Compounded semaglutide typically has shorter room temperature limits (14-21 days for pre-filled syringes, refrigeration required for reconstituted vials). Always follow the specific storage instructions on your compounding pharmacy label.

Sources

1. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. FDA-approved labeling. 2017, revised 2024.
2. Buckley ST et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine. 2018.
3. Jensen L et al. Stability and degradation pathways of semaglutide under various storage conditions. Pharmaceutical Research. 2021.
4. Thorisdottir RL et al. Effects of freeze-thaw cycles on GLP-1 analog structural integrity and bioactivity. European Journal of Pharmaceutics and Biopharmaceutics. 2019.
5. Morrison KL et al. Temperature cycling effects on peptide drug stability in prefilled injection devices. Diabetes Technology & Therapeutics. 2022.
6. FDA. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. 1999.
7. USP Chapter 1079. Good Storage and Distribution Practices for Drug Products. United States Pharmacopeia. 2023.
8. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
9. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021.
10. Lau J et al. Discovery of the once-weekly glucagon-like peptide-1 analog semaglutide. Journal of Medicinal Chemistry. 2015.
11. Kalra S et al. Storage of insulin and GLP-1 receptor agonists in real-world settings. Diabetes Therapy. 2020.
12. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026.
13. WHO. Guidelines on the international packaging and shipping of vaccines. World Health Organization. 2022.
14. Mathaes R et al. Subcutaneous injection volume of biopharmaceuticals: pushing the boundaries. Journal of Pharmaceutical Sciences. 2016.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, NovoCare, and Rybelsus are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.